Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/JW-CAYMAN-THERAPEUTICS-CO-119080133/nieuws/JW-Therapeutics-kondigt-de-start-aan-van-een-klinische-studie-van-JWATM204-bij-patienten-met-gevord-40896969/?utm_source=whatsapp&utm_medium=social&utm_campaign=share